期刊文献+

359例血友病A实验室诊断数据回顾分析

下载PDF
导出
摘要 目的调查分析本院血友病A患者的实验室诊断数据,了解医院就诊血友病A临床分型、抑制物存在情况及获得性血友病的诊断思路,为临床诊断和治疗提供证据。方法对患者进行活化部分凝血活酶时间(APTT)和Ⅷ因子活性(FⅧ∶C)检测,抑制物筛查采用APTT纠正试验做定性判断,阳性者用Nijmegen定量检测抗体。结果 359名血友病A患者以重型和中型居多(共占81%),亚临床型仅14例。抑制物筛查22例阳性,FⅧ抗体定量检测平均抗体滴度35 BU。获得性血友病1例;2例患者同时存在FⅧ∶C、FⅨ∶C低下和抑制物阳性。结论医院就诊的血友病A患者主要为重型和中型,亚临床型少见;FⅧ抑制物筛查及抗体滴度在临床治疗方案选择中及其重要;获得性血友病诊断思路应该为实验室数据结合临床、遗传学、自身免疫性检查等。
机构地区 江西省人民医院
出处 《中国输血杂志》 CAS CSCD 北大核心 2013年第8期737-739,共3页 Chinese Journal of Blood Transfusion
  • 相关文献

参考文献12

  • 1王学锋,凝血因子缺陷所致出血//王振义,李家增,阮长耿,等.血栓与止血基础理论与临床.上海:上海科学技术出版社.2004:300-402.
  • 2赵永强,临床表现//杨仁池,王鸿利.血友病.上海:上海科学技术出版社,2007:36-113.
  • 3姬文灿,丁凯阳,吴竞生.凝血因子Ⅷ抑制物的研究进展[J].血栓与止血学,2010,16(1):43-46. 被引量:3
  • 4Goudemand J, Laurian Y, Calvez T. Risk of inhibitors in haemophil- ia and the type of factor replacement. Current Opinion Hematol, 2006,13(5) :316-322.
  • 5Ewenstein BM, Gomperts ED, Pearson S, et al. Inhibitor develop- ment in patients receiving recombinant factor V: (Recombinate rAHF/Bioclate) : a prospective pharmacovigilance study. Haemo- phil ,2004,10 (5) :491-498.
  • 6Kempton CL,Soucie JM,Abshire TC. Incidence of inhibitors in a co- hort of 838 males with hemophilia A previously treated with factor V: concentrates. J Thrombosis 'and Haemostasis ,2006,4(12) :2576-2581.
  • 7Gouw SC, van der Born JG, Auerswald G, et al. Recombinant versusplasma-derived factor : products and the development of inhibitors in previously untreated patients With severe hemophilia A:the CA- NAL cohort study. Blood ,2007,109 ( 11 ) :4693-4697.
  • 8王学锋,郭英华,病理性抗凝物质检测//王学峰,王鸿利.血栓与止血的检测及应用.上海:世界图书出版公司,2001:246-248.
  • 9Boggio LN, Green D. Acquired haemophilia. Rev Clin Exp Hema- tol,2001,5(4) :389-404.
  • 10Franchini M, Gandini G, Di Paolantonio T, et al. Acquired Hemo- philia A:A Concise Review. Am J Hematol,2005,80( 1 ) :55-63.

二级参考文献57

  • 1郑卫东,曾淑燕,范小斌.Nijmegen测定法的简化及其在凝血因子抑制物检测中的应用[J].实用医学杂志,2005,21(13):1475-1477. 被引量:1
  • 2郑昌成,吴竞生.获得性血友病[J].血栓与止血学,2005,11(6):279-283. 被引量:2
  • 3Scandella D, Nakai H, Felch M, et al. In hemophilia A and antoantibody inhibitor patients: the factor Ⅷ A2 domain and light chain are most immunogenic. Thromb Ros, 2001,101 (5): 377-385.
  • 4Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ special autoimmune disease. Haemophilia, 2001,7 (5) :523-525.
  • 5吴竞生.非血友病患者的抑制物//杨仁池,王鸿利.血友病.上海:上海科技出版社,2007,113-122.
  • 6Boggio LN, Green D. Acquired haemophilia. Rev Clin Exp Heamatol,2001,5(4) :389-404.
  • 7Franchini M, Gandini G, Paolantonio TD, et al. Acquired Hemophilia A :A Concise Review. American J of Hematology,2005,80 (1) :55-63.
  • 8Theodossiades G, Kontopoulou-Griva I. Acquired hemophilia A.Haematology ,2002,5 (4) :282-290.
  • 9Lillicrap D, Nair SC, Srivestava A, et al. Laboratory issues in bleeding disorders. Haemophilia, 2006,12(3) :68-75.
  • 10Di Bona E, Sehiavoni M, Castaman G, et al. Acquired haemophilia: experience of two Italian centres with 17 new cases. Haemophilia, 1997,3(3) :183-188.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部